Effectiveness Comparison of Third-Generation EGFR-TKI As Initial and Sequential Therapy in Adjuvant Treatment for EGFR Mutation-Sensitive Stage IIIA Non-Small Cell Lung Cancer after Surgery
HELIYON（2023）
Key words
EGFR mutation,Lung adenocarcinoma,Stage IIIA,Osimertinib,First-generation TKIs,Treatment sequential,Survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined